TITLE

Clinicopathological Characteristics And EGFR-TKIs Efficacies In Lung Squamous Cell Carcinoma Patients Harboring An EGFR Sensitizing Mutation

AUTHOR(S)
Zhou, Shaozhang; Wang, Huilin; Jiang, Wei; Yu, Qitao
PUB. DATE
October 2019
SOURCE
OncoTargets & Therapy;Oct2019, Vol. 12, p8863
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Squamous cell lung carcinoma, epidermal growth factor receptor mutation, clinicopathologic features, tyrosine kinase inhibitors.
ACCESSION #
139528610

 

Related Articles

  • Clinical And Imageological Features Of Lung Squamous Cell Carcinoma With EGFR Mutations. Gao, Xuejuan; Zhu, Junjie; Chen, Linsong; Jiang, Yan; Zhou, Xiao; Shuai, Jianwei; Zhao, Yanfeng // Cancer Management & Research;Oct2019, Vol. 11, p9017 

    Purpose: To analyze the distribution of epidermal growth factor receptor (EGFR) mutations; characterize the clinical and imageological features of lung squamous cell carcinoma (LSCC) in a large population of patients; and assess correlations between clinical and imageological characteristics and...

  • Clinical Snippets.  // Journal of Investigative Dermatology;Oct2014, Vol. 134 Issue 10, p2480 

    An introduction is presented related to the exon sequencing of cutaneous squamous cell carcinomas, the implication of epidermal growth factor receptor (EFGR) signaling in malignant diseases and the effect of imiquimod in combating melanoma.

  • Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis. Meka, Naga Jyothi; Ugrappa, Sridevi; Velpula, Nagalaxmi; Kumar, Sravan; Naik Maloth, Kotya; Kodangal, Srikanth; Lalitha ch; Goyal, Stuti // Journal of Dental Research, Dental Clinics, Dental Prospects;Summer2015, Vol. 9 Issue 3, p166 

    Background and aims. Many oral squamous cell carcinomas develop from potentially malignant disorders (PMDs) which include a variety of lesions and conditions characterized by an increased risk for malignant transformation. This study evaluated the quantitative expression of EGFR in normal oral...

  • P-0184CORRELATION OF KRAS STATUS WITH CETUXIMAB ACTIVITY IN HEAVILY TREATED PATIENTS WITH SQUAMOUS CELL ANAL CARCINOMA. Dal Molin, Graziela; Macedo, Mariana; Begnami, Maria Dirlei; Collares, Barbara; Conte, Bruno; Fanelli, Marcello Ferretti; Dettino, Aldo; Mello, Celso // Annals of Oncology;Jun2013, Vol. 24 Issue suppl_4, piv88 

    No abstract available.

  • Specific and Sensitive Hydrolysis Probe-Based Real-Time PCR Detection of Epidermal Growth Factor Receptor Variant III in Oral Squamous Cell Carcinoma. McIntyre, John B.; Bose, Pinaki; Klimowicz, Alexander C.; Brockton, Nigel T.; Petrillo, Stephanie; Matthews, Wayne; Easaw, Jay; Magliocco, Anthony; Dort, Joseph C. // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Background: The tumor-specific EGFR deletion mutant, EGFRvIII, is characterised by ligand-independent constitutive signalling. Tumors expressing EGFRvIII are resistant to current EGFR-targeted therapy. The frequency of EGFRvIII in head and neck squamous cell carcinoma (HNSCC) is disputed and may...

  • Evaluation of biologic markers in squamous cell carcinoma biopsy samples of the tongue and correlation with neck lymph node metastasis. Madani Kermani, Z.; Khorsandi, M. T.; Yazdani, N.; Mirashrafi, F. // Tehran University Medical Journal;Oct2009, Vol. 67 Issue 7, p502 

    Background: Neck lymph node metastasis has the prognostic role in SCC of the tongue and the importance of the biologic markers in tumor invasion and metastasis has been stated in the medical literature. The aim of this study was to evaluate the relationship between two biomarkers, p53 and EGFR...

  • PET imaging of EGF receptors using [F]FBEM-EGF in a head and neck squamous cell carcinoma model. Li, Weihua; Niu, Gang; Lang, Lixin; Guo, Ning; Ma, Ying; Kiesewetter, Dale; Backer, Joseph; Shen, Baozhong; Chen, Xiaoyuan // European Journal of Nuclear Medicine & Molecular Imaging;Feb2012, Vol. 39 Issue 2, p300 

    Purpose: To prepare and evaluate a new radiotracer for molecular imaging of cell surface receptors for epidermal growth factor (EGF). Methods: Cys-tagged EGF (cEGF) was labeled with F by coupling the free thiol group of the Cys tag with N-[2-(4-[F]fluorobenzamido)ethyl]maleimide ([F]FBEM) to...

  • Targeting TORC1/2 Enhances Sensitivity to EGFR Inhibitors in Head and Neck Cancer Preclinical Models. Cassell, Andre; Freilino, Maria L.; Lee, Jessica; Barr, Sharon; Lin Wang; Panahandeh, Mary C.; Thomas, Sufi M.; Grandis, Jennifer R. // Neoplasia;Nov2012, Vol. 14 Issue 11, p1005 

    Head and neck squamous cell carcinoma (HNSCC) is characterized by overexpression of the epidermal growth factor receptor (EGFR) where treatments targeting EGFR have met with limited clinical success. Elucidation of the key downstreampathways that remain activated in the setting of EGFR blockade...

  • Podoplanin promotes cell migration via the EGF-Src-Cas pathway in oral squamous cell carcinoma cell lines. Inoue, Harumi; Miyazaki, Yuji; Kikuchi, Kentaro; Yoshida, Noriaki; Ide, Fumio; Ohmori, Yoshihiro; Tomomura, Akihito; Sakashita, Hideaki; Kusama, Kaoru // Journal of Oral Science;Sep2012, Vol. 54 Issue 3, p241 

    Human podoplanin is a type-1 trans-membrane sialomucin-like glycoprotein that is involved in cell migration, tumor cell invasion and metastasis. Our recent study of oral squamous cell carcinoma (OSCC) demonstrated that the degree of immunohistochemical expression of podoplanin was correlated...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics